Benzinga | Sep 3, 2021 06:34AM EDT

Oppenheimer Maintains Outperform on DocuSign, Raises Price Target to $310

Oppenheimer analyst Brian Schwartz maintains DocuSign (NASDAQ:DOCU) with a Outperform and raises the price target from $260 to $310.